Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 80,873 | 90,884 | 214,985 | -87,747 | -67,381 |
| Depreciation Amortization | 21,691 | 10,786 | 46,688 | 35,921 | 24,815 |
| Income taxes - deferred | 14,436 | 13,549 | -290,516 | N/A | N/A |
| Accounts receivable | -16,255 | 4,908 | 47,595 | 48,223 | 46,193 |
| Accounts payable and accrued liabilities | -16,104 | -17,191 | -655 | -13,606 | -14,239 |
| Other Working Capital | -124,046 | -53,033 | 499,425 | 441,532 | 493,226 |
| Other Operating Activity | 119,999 | 57,802 | 85,384 | 63,075 | 30,788 |
| Operating Cash Flow | $80,594 | $107,705 | $602,906 | $487,398 | $513,402 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -171,308 | -65,913 | -911,911 | -587,818 | -284,854 |
| PPE Investments | -7,243 | -3,229 | -13,608 | -12,221 | -8,977 |
| Purchase Sale Intangibles | -2,310 | -1,032 | -4,044 | -3,317 | -1,854 |
| Other Investing Activity | -2,310 | -1,032 | -4,044 | -3,317 | -1,854 |
| Investing Cash Flow | $-180,861 | $-70,174 | $-929,563 | $-603,356 | $-295,685 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 102,004 | 67,057 | 475,865 | 466,219 | 458,143 |
| Other Financing Activity | -8,034 | -7,597 | 0 | 0 | 0 |
| Financing Cash Flow | $93,970 | $59,460 | $475,865 | $466,219 | $458,143 |
| Exchange Rate Effect | N/A | N/A | -18 | N/A | N/A |
| Beginning Cash Position | 278,820 | 278,820 | 129,630 | 129,630 | 129,630 |
| End Cash Position | 272,523 | 375,811 | 278,820 | 479,891 | 805,490 |
| Net Cash Flow | $-6,297 | $96,991 | $149,190 | $350,261 | $675,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | 80,594 | 107,705 | 602,906 | 487,398 | 513,402 |
| Capital Expenditure | -7,243 | -3,229 | -13,608 | -12,221 | -8,977 |
| Free Cash Flow | 73,351 | 104,476 | 589,298 | 475,177 | 504,425 |